PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
PRECIGEN, INC.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026
$6.66+0.28 (+4.31%)
Close on Oct 19, 2026
- Market cap
- $2.76B
- P/E (TTM)
- –
- Dividend yield
- –
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
39.2%
140M of 358M shares
Institutional holders
211
37 new, 28 sold out
Net institutional buying
7M
In Q2 2026
Insider trades, 12 months
1 buys · 42 sales
Net sold $44.76M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Patient Capital Management, LLC | 36,006,800 | 10.20% | 13G (passive) amendment | Dec 31, 2025 |
| William H. Miller III Living Trust dated April 17, 2017 | 34,051,925 | 9.20% | 13G (passive) | Jun 26, 2025 |
| Ares Trading SA | 20,647,152 | 8.30% | 13G (passive) amendment | Feb 14, 2024 |
| Steven A. Cohen | 18,383,242 | 5.20% | 13G (passive) | Jan 22, 2026 |
| Randal J. Kirk | 133,956,416 | 35.90% | 13D (active) amendment | Mar 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of PGEN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| Patient Capital Management, LLC | 19,036,976 | 5.32% | $108.51M | +1,219,589 | 3.56% |
| BlackRock, Inc. | 17,146,921 | 4.79% | $97.74M | +1,923,730 | 0.00% |
| State Street Corp | 12,002,465 | 3.35% | $68.41M | +1,112,341 | 0.00% |
| Diametric Capital, LP | 9,269,926 | 2.59% | $52.84M | +2,468,138 | 5.57% |
| Vanguard Capital Management LLC | 7,906,160 | 2.21% | $45.07M | +757,164 | 0.00% |
| Tang Capital Management LLC | 6,417,500 | 1.79% | $36.58M | – | 1.66% |
| Boxer Capital Management, LLC | 5,150,000 | 1.44% | $29.36M | +1,650,000 | 2.21% |
| Geode Capital Management, LLC | 5,019,028 | 1.40% | $28.61M | +405,599 | 0.00% |
| Iridian Asset Management LLC/Ct | 4,031,963 | 1.13% | $22.98M | +439,233 | 7.90% |
| Occam Crest Management LP | 3,605,941 | 1.01% | $19.65M | −663,110 | 10.20% |
| Morgan Stanley | 3,469,628 | 0.97% | $19.78M | +1,055,306 | 0.00% |
| Goldman Sachs Group Inc | 3,406,456 | 0.95% | $19.42M | +55,979 | 0.00% |
| FMR LLC | 2,570,183 | 0.72% | $14.65M | +571,587 | 0.00% |
| Vanguard Portfolio Management LLC | 2,211,172 | 0.62% | $12.60M | +95,161 | 0.00% |
| First Trust Advisors LP | 2,014,659 | 0.56% | $11.48M | New | 0.01% |
| Bank Of America Corp /De/ | 1,848,414 | 0.52% | $10.54M | +377,135 | 0.00% |
| Arrowstreet Capital, Limited Partnership | 1,788,235 | 0.50% | $10.19M | +1,392,540 | 0.00% |
| Northern Trust Corp | 1,779,380 | 0.50% | $10.14M | +167,590 | 0.00% |
| Charles Schwab Investment Management Inc | 1,515,853 | 0.42% | $8.64M | +55,233 | 0.00% |
| Woodline Partners LP | 1,401,945 | 0.39% | $7.99M | +533 | 0.02% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 211 | 140M | 39.2% | 37 / 86 | 46 / 28 | 24M | 17M |
| Q1 2026 | 206 | 134M | 37.3% | 48 / 67 | 47 / 17 | 30M | 22M |
| Q4 2025 | 179 | 136M | 38.1% | 36 / 78 | 32 / 19 | 47M | 22M |
| Q3 2025 | 167 | 112M | 31.3% | 39 / 50 | 43 / 18 | 46M | 16M |
| Q2 2025 | 147 | 82M | 23.0% | 23 / 45 | 33 / 13 | 8M | 6M |
| Q1 2025 | 138 | 80M | 22.4% | 23 / 34 | 42 / 17 | 9M | 4M |
| Q4 2024 | 133 | 76M | 21.2% | 26 / 42 | 28 / 19 | 5M | 5M |
| Q3 2024 | 127 | 76M | 21.3% | 16 / 37 | 32 / 17 | 28M | 3M |
| Q2 2024 | 130 | 62M | 17.3% | 16 / 42 | 38 / 13 | 3M | 6M |
| Q1 2024 | 129 | 65M | 18.2% | 9 / 35 | 45 / 15 | 5M | 5M |
| Q4 2023 | 137 | 65M | 18.2% | 18 / 35 | 44 / 19 | 10M | 5M |
| Q3 2023 | 138 | 61M | 16.9% | 13 / 41 | 38 / 12 | 8M | 5M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of PGEN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Patient Opportunity Trust | 12,900,000 | 3.60% | $73.53M | 3.66% | Jun 30, 2026 |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | 7,085,516 | 1.98% | $40.39M | 0.38% | Jun 30, 2026 |
| Vanguard Total Stock Market Index Fund | 5,690,796 | 1.59% | $32.44M | 0.00% | Jun 30, 2026 |
| iShares Russell 2000 ETF | 4,955,744 | 1.38% | $28.25M | 0.03% | Jun 30, 2026 |
| Fidelity Small Cap Index Fund | 2,109,412 | 0.59% | $13.23M | 0.04% | Jul 31, 2026 |
| Vanguard Extended Market Index Fund | 2,020,238 | 0.56% | $11.52M | 0.01% | Jun 30, 2026 |
| iShares Russell 2000 Growth ETF | 1,782,218 | 0.50% | $10.16M | 0.07% | Jun 30, 2026 |
| Fidelity Small Cap Growth Fund | 1,678,323 | 0.47% | $10.52M | 0.12% | Jul 31, 2026 |
| First Trust Small Cap Growth AlphaDEX Fund | 1,539,558 | 0.43% | $9.65M | 0.74% | Jul 31, 2026 |
| iShares Biotechnology ETF | 1,116,872 | 0.31% | $6.37M | 0.07% | Jun 30, 2026 |
| Vanguard Russell 2000 Index Fund | 926,370 | 0.26% | $4.02M | 0.02% | May 31, 2026 |
| Fidelity Extended Market Index Fund | 915,322 | 0.26% | $3.97M | 0.01% | May 31, 2026 |
| Fidelity Small Cap Growth K6 Fund | 870,590 | 0.24% | $5.46M | 0.12% | Jul 31, 2026 |
| Schwab U.S. Small-Cap ETF | 839,393 | 0.23% | $3.64M | 0.02% | May 31, 2026 |
| First Trust Small Cap Core AlphaDEX Fund | 765,206 | 0.21% | $4.80M | 0.35% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Harry Thomasian Jr. | Chief Financial Officer | 311,911 | 0.09% | Sep 24, 2026 |
| Donald P. Lehr | Chief Legal Officer | 758,181 | 0.21% | Aug 25, 2026 |
| Phil Tennant | Chief Commercial Officer | 221,158 | 0.06% | Aug 25, 2026 |
| Helen Sabzevari | President and CEO | 3,789,705 | 1.06% | Aug 25, 2026 |
| Rutul R. Shah | Chief Operating Officer | 468,865 | 0.13% | Aug 25, 2026 |
| Jeffrey B. Kindler | Director | 17,100 | 0.00% | Aug 28, 2026 |
| Nancy H. Agee | Director | 309,187 | 0.09% | Aug 25, 2026 |
| Randal J. Kirk | Director, 10% owner | 116,301,090 | 32.48% | Mar 31, 2026 |
| Vinita D. Gupta | Director | 669,027 | 0.19% | Mar 16, 2026 |
| Fred Hassan | Director | 1,243,239 | 0.35% | Mar 16, 2026 |
| Cesar L. Alvarez | Director | 782,909 | 0.22% | Mar 16, 2026 |
| Steven Frank | Director | 1,226,391 | 0.34% | Mar 16, 2026 |
| James S. Turley | Director | 685,417 | 0.19% | Mar 16, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +42,918 | $2.33 | $100.00K | 311,911 |
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +2 | $0.96 | $2 | 311,913 |
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +1 | $1.21 | $1 | 311,914 |
| Harry Thomasian Jr. Chief Financial Officer | Sep 23, 2026 | Option exercise | +10,744 | $4.72 | $50.71K | 268,993 |
| Jeffrey B. Kindler Director | Aug 26, 2026 | Sale | −185,000 | $7.44 | $1.38M | 17,100 |
| Phil Tennant Chief Commercial Officer | Aug 25, 2026 | Option exercise | +79,166 | $1.61 | $127.46K | 221,158 |
| Phil Tennant Chief Commercial Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −79,166 | $7.50 | $593.75K | 141,992 |
| Rutul R. Shah Chief Operating Officer | Aug 25, 2026 | Sale(10b5-1 plan) | −15,342 | $7.50 | $115.07K | 468,865 |
| Rutul R. Shah Chief Operating Officer | Aug 25, 2026 | Option exercise | +15,342 | $2.33 | $35.75K | 484,207 |
| Phil Tennant Chief Commercial Officer | Aug 23, 2026 | Option exercise | +5,208 | – | – | 144,577 |
| Phil Tennant Chief Commercial Officer | Aug 23, 2026 | Tax withholding | −2,585 | $7.20 | $18.61K | 141,992 |
| Rutul R. Shah Chief Operating Officer | Aug 23, 2026 | Tax withholding | −3,647 | $7.20 | $26.26K | 468,865 |
| Rutul R. Shah Chief Operating Officer | Aug 23, 2026 | Option exercise | +7,500 | – | – | 472,512 |
| Helen Sabzevari President and CEO | Aug 23, 2026 | Option exercise | +20,833 | – | – | 3,789,705 |
| Helen Sabzevari President and CEO | Aug 23, 2026 | Tax withholding | −10,184 | $7.20 | $73.32K | 3,779,521 |
| Harry Thomasian Jr. Chief Financial Officer | Aug 23, 2026 | Tax withholding | −3,577 | $7.20 | $25.75K | 258,249 |
| Harry Thomasian Jr. Chief Financial Officer | Aug 23, 2026 | Option exercise | +7,291 | – | – | 261,826 |
| Donald P. Lehr Chief Legal Officer | Aug 23, 2026 | Tax withholding | −2,488 | $7.20 | $17.91K | 758,181 |
| Donald P. Lehr Chief Legal Officer | Aug 23, 2026 | Option exercise | +5,208 | – | – | 760,669 |
| Rutul R. Shah Chief Operating Officer | Aug 21, 2026 | Sale(10b5-1 plan) | −34,658 | $7.50 | $259.94K | 465,012 |
| Rutul R. Shah Chief Operating Officer | Aug 21, 2026 | Option exercise | +34,658 | $2.33 | $80.75K | 499,670 |
| Nancy H. Agee Director | Aug 21, 2026 | Buy | +3,411 | $7.23 | $24.66K | 309,187 |
| Rutul R. Shah Chief Operating Officer | Aug 6, 2026 | Sale(10b5-1 plan) | −32,739 | $6.86 | $224.59K | 465,012 |
| Rutul R. Shah Chief Operating Officer | Aug 3, 2026 | Option exercise | +33,772 | $2.33 | $78.69K | 531,523 |
| Rutul R. Shah Chief Operating Officer | Aug 3, 2026 | Sale(10b5-1 plan) | −33,772 | $6.50 | $219.52K | 497,751 |
| Harry Thomasian Jr. Chief Financial Officer | Jul 31, 2026 | Sale(10b5-1 plan) | −100,000 | $6.06 | $606.00K | 254,535 |
| Harry Thomasian Jr. Chief Financial Officer | Jul 1, 2026 | Sale(10b5-1 plan) | −171,429 | $5.53 | $948.00K | 354,535 |
| Helen Sabzevari President and CEO | Jun 29, 2026 | Sale(10b5-1 plan) | −346,836 | $5.89 | $2.04M | 3,768,872 |
| Helen Sabzevari President and CEO | Jun 29, 2026 | Option exercise | +346,836 | $2.33 | $808.13K | 4,115,708 |
| Harry Thomasian Jr. Chief Financial Officer | Jun 29, 2026 | Sale(10b5-1 plan) | −28,571 | $5.78 | $165.14K | 525,964 |
| Rutul R. Shah Chief Operating Officer | Jun 29, 2026 | Sale(10b5-1 plan) | −42,924 | $5.85 | $251.11K | 497,751 |
| Rutul R. Shah Chief Operating Officer | Jun 29, 2026 | Option exercise | +42,924 | $2.33 | $100.01K | 540,675 |
| Phil Tennant Chief Commercial Officer | May 28, 2026 | Sale | −30,272 | $4.36 | $131.99K | 139,369 |
| Donald P. Lehr Chief Legal Officer | May 28, 2026 | Sale | −29,131 | $4.36 | $127.01K | 755,461 |
| Harry Thomasian Jr. Chief Financial Officer | May 28, 2026 | Sale | −41,884 | $4.36 | $182.61K | 554,535 |
| Rutul R. Shah Chief Operating Officer | May 28, 2026 | Sale | −42,703 | $4.36 | $186.19K | 497,751 |
| Helen Sabzevari President and CEO | May 28, 2026 | Sale | −119,250 | $4.36 | $519.93K | 3,768,872 |
| Helen Sabzevari President and CEO | May 23, 2026 | Option exercise | +250,000 | – | – | 3,888,122 |
| Phil Tennant Chief Commercial Officer | May 23, 2026 | Option exercise | +62,500 | – | – | 169,641 |
| Harry Thomasian Jr. Chief Financial Officer | May 23, 2026 | Option exercise | +87,500 | – | – | 596,419 |
| Donald P. Lehr Chief Legal Officer | May 23, 2026 | Option exercise | +62,500 | – | – | 784,592 |
| Rutul R. Shah Chief Operating Officer | May 23, 2026 | Option exercise | +90,000 | – | – | 540,454 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −1,108,998 | $3.30 | $3.66M | 80,672,818 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −38,976 | $3.30 | $128.62K | 302,213 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −2,334,420 | $3.30 | $7.70M | 12,262,741 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −23,789 | $3.30 | $78.50K | 423,984 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −50,797 | $3.30 | $167.63K | 426,695 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −370,847 | $3.30 | $1.22M | 3,238,210 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −152,063 | $3.30 | $501.81K | 1,463,571 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −50,797 | $3.30 | $167.63K | 425,732 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −426,199 | $3.30 | $1.41M | 3,358,917 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −168,794 | $3.30 | $557.02K | 1,425,544 |
| Randal J. Kirk Director, 10% owner | Mar 30, 2026 | Sale | −47,101 | $3.30 | $155.43K | 519,061 |
| Helen Sabzevari President and CEO, Director | Mar 18, 2026 | Option exercise | +321,100 | – | – | 3,638,122 |
| Phil Tennant Chief Commercial Officer | Mar 18, 2026 | Option exercise | +42,110 | – | – | 107,141 |
| Donald P. Lehr Chief Legal Officer | Mar 18, 2026 | Option exercise | +40,443 | – | – | 722,092 |
| Rutul R. Shah Chief Operating Officer | Mar 18, 2026 | Option exercise | +44,495 | – | – | 450,454 |
| Harry Thomasian Jr. Chief Financial Officer | Mar 18, 2026 | Option exercise | +40,293 | – | – | 508,919 |
| Randal J. Kirk Director, 10% owner | Mar 13, 2026 | Option exercise | +143,678 | – | – | 81,781,816 |
| James S. Turley Director | Mar 13, 2026 | Option exercise | +71,839 | – | – | 685,417 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Kindler Jeffrey Director | Aug 26, 2026 | 185,000 | $1.37M | Aug 26, 2026 | Acquired as compensation -- Restricted Stock Units |
| Phil Tennant Officer | Aug 25, 2026 | 79,166 | $593.75K | Aug 25, 2026 | Stock Option Exercise |
| Rutul R. Shah Officer | Aug 25, 2026 | 15,342 | $115.07K | Aug 25, 2026 | Stock Option Exercise |
| Rutul R. Shah Officer | Aug 21, 2026 | 34,658 | $259.94K | Aug 21, 2026 | Stock Option Exercise |
| Rutul R. Shah Officer | Aug 6, 2026 | 32,739 | $224.59K | Aug 6, 2026 | Restricted Stock Vesting |
| Rutul R. Shah Officer | Aug 3, 2026 | 33,772 | $219.52K | Aug 3, 2026 | Stock Option Exercise |
| Harry Thomasian Jr. Officer | Jul 31, 2026 | 100,000 | $605.61K | Jul 31, 2026 | Restricted Stock Vesting |
| Harry Thomasian Jr. Officer | Jul 1, 2026 | 171,429 | $948.54K | Jul 1, 2026 | Restricted Stock Vesting |
| Harry Thomasian Jr. Officer | Jun 29, 2026 | 28,571 | $165.20K | Jun 29, 2026 | Open Market Purchase |
| Rutul R. Shah Officer | Jun 29, 2026 | 42,924 | $251.11K | Jun 29, 2026 | Stock Option Exercise |
| Helen Sabzevari Officer, Director | Jun 29, 2026 | 346,836 | $2.04M | Jun 29, 2026 | Stock Option Exercise |
| J. Kirk Randal Director, 10% Shareholder | Mar 30, 2026 | 4,772,781 | $17.52M | Mar 30, 2026 | Private Placement |
| J. Kirk Randal Director, 10% Shareholder | Dec 22, 2025 | 1,900,036 | $8.21M | Dec 22, 2025 | Secondary Public Offering |
| Kindler Jeffrey Director | Dec 12, 2025 | 235,467 | $868.87K | Dec 12, 2025 | Acquired as compensation -- Restricted Stock Units |
| Randal J. Kirk Director, 10% Stockholder | Nov 20, 2025 | 942,832 | $3.84M | Nov 20, 2025 | Public offering of shares by Company |